Aktie A043100 SOLCO BIOMEDICAL CO., LTD.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Solco Biomedical Co., Ltd.

Aktien

A043100

KR7043100007

A043100

Schlusskurs Korea S.E.
Andere Börsenplätze
 00:00:00 28.06.2024 		% 5 Tage % 1. Jan.
286 KRW 0.00% Intraday Chart für Solco Biomedical Co., Ltd. -29.73% -31.25%
2023 Solco Biomedical Co., Ltd. meldet Ergebnis für das erste Quartal bis zum 31. März 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Solco Biomedical Co., Ltd. announced that it expects to receive KRW 13 billion in funding from MDS Intelligence Inc.
Solco Biomedical Co., Ltd. announced that it has received KRW 900 million in funding
Solco Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
CTL Biotech Co., Ltd announced that it expects to receive KRW 120 million in funding from Solco Biomedical Co., Ltd.
Gilon Co., Ltd. announced that it has received KRW 500 million in funding from Solco Biomedical Co., Ltd.
Gilon Co., Ltd. announced that it expects to receive KRW 500 million in funding from Solco Biomedical Co., Ltd.
Solco Biomedical Co., Ltd. announced that it has received KRW 2.1 billion in funding
Solco Biomedical Co., Ltd. announced that it has received KRW 1.5 billion in funding
Solco Biomedical Co., Ltd. announced that it has received KRW 3 billion in funding from CAPE Investment & Securities Co.,Ltd., Investment Arm and another investor
Solco Biomedical Co., Ltd. announced that it expects to receive KRW 1.5 billion in funding
Bionet Co. Ltd. announced that it has received KRW 1.75 billion in funding from Solco Biomedical Co., Ltd.
Solco Biomedical Co. Ltd. announced that it has received KRW 3.5 billion in funding
Solco Biomedical Co. Ltd. announced that it expects to receive KRW 3.5 billion in funding
Solco Biomedical Co. Ltd. announced that it has received KRW 3 billion in funding from Sejong Mutual Savings Bank Co.,Ltd., Investment Arm.
Solco Biomedical Co. Ltd. announced that it expects to receive KRW 3 billion in funding from Sejong Mutual Savings Bank Co.,Ltd., Investment Arm.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A043100 Aktie
  4. Nachrichten Solco Biomedical Co., Ltd.
  5. Andere Sprachen